Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126959242 | 12695924 | 2 | F | 20160811 | 20160903 | 20160829 | 20160914 | EXP | US-ACTELION-A-NJ2016-141218 | ACTELION | 58.00 | YR | A | F | Y | 0.00000 | 20160914 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126959242 | 12695924 | 1 | PS | TRACLEER | BOSENTAN | 1 | Oral | 125 MG, BID | OP026P0101 | 21290 | 125 | MG | TABLET | BID | |||||
126959242 | 12695924 | 2 | C | TYVASO | TREPROSTINIL | 1 | U | 0 | |||||||||||
126959242 | 12695924 | 3 | C | REVATIO | SILDENAFIL CITRATE | 1 | U | 0 | |||||||||||
126959242 | 12695924 | 4 | C | COUMADIN | WARFARIN SODIUM | 1 | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126959242 | 12695924 | 1 | Pulmonary arterial hypertension |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126959242 | 12695924 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126959242 | 12695924 | Hernia repair | |
126959242 | 12695924 | Pain | |
126959242 | 12695924 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126959242 | 12695924 | 1 | 20061101 | 0 |